Literature DB >> 21112656

Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection.

Yi-Wei Li1, Shuang-Jian Qiu, Jia Fan, Jian Zhou, Qiang Gao, Yong-Sheng Xiao, Yong-Feng Xu.   

Abstract

BACKGROUND & AIMS: Neutrophil infiltration has been linked to clinical outcome of various cancer types. However, its role in hepatocellular carcinoma (HCC) is unclear. In this study, we investigated prognostic values for intratumoral and peritumoral neutrophils in HCC patients undergoing curative resection.
METHODS: The expression of CD66b, CD8, TGF-beta, and CD34 was assessed by immunohistochemistry in tissue microarrays containing paired intratumoral and peritumoral tissues from 197 patients receiving curative resection for HCC. Prognostic values for these and other clinicopathologic factors were evaluated.
RESULTS: Intratumoral CD66b(+) neutrophils significantly correlated with CD8(+) T cells (r=0.240, p=0.004), TGF-beta expression (p=0.012), BCLC stage (p=0.016), and early recurrence (p=0.041). Increased intratumoral neutrophils were significantly associated with decreased RFS/OS (p=0.001 and p<0.001, respectively) in univariate analysis and were identified as an independent prognostic factor (HR=1.845, 95% CI=1.169-2.911, p=0.008 for RFS; HR=2.578, 95% CI=1.618-4.106, p<0.001 for OS) in multivariate analysis. Intratumoral neutrophil-to-CD8(+) T cell ratio (iNTR) better predicted the outcome in terms of minimum p values. Intratumoral neutrophils were also demonstrated to be statistically predictive for RFS/OS in the normal AFP subgroup, small HCC subgroup, and validation cohort. However, peritumoral neutrophils were not associated with the outcome of HCC.
CONCLUSIONS: The presence of intratumoral neutrophils was a poor prognostic factor for HCC after resection. Intratumoral neutrophil-to-CD8(+) T cell ratio was a better predictor of outcome. Copyright Â
© 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21112656     DOI: 10.1016/j.jhep.2010.07.044

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  123 in total

Review 1.  Neutrophils in the Tumor Microenvironment.

Authors:  Davalyn R Powell; Anna Huttenlocher
Journal:  Trends Immunol       Date:  2015-12-14       Impact factor: 16.687

2.  Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes.

Authors:  Qian Zhu; Mu-Yan Cai; Chang-Long Chen; Hao Hu; Huan-Xin Lin; Min Li; De-Sheng Weng; Jing-Jing Zhao; Ling Guo; Jian-Chuan Xia
Journal:  Oncoimmunology       Date:  2017-04-27       Impact factor: 8.110

3.  Co-expression of carcinoembryonic antigen-related cell adhesion molecule 6 and 8 inhibits proliferation and invasiveness of breast carcinoma cells.

Authors:  Erina Iwabuchi; Yasuhiro Miki; Yoshiaki Onodera; Yukiko Shibahara; Kiyoshi Takagi; Takashi Suzuki; Takanori Ishida; Hironobu Sasano
Journal:  Clin Exp Metastasis       Date:  2019-06-20       Impact factor: 5.150

4.  Liver transplantation: a simple inflammation marker predicts liver cancer prognosis.

Authors:  Zhao-You Tang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-07-04       Impact factor: 46.802

5.  Tumor-infiltrating neutrophils predict therapeutic benefit of tyrosine kinase inhibitors in metastatic renal cell carcinoma.

Authors:  Jiajun Wang; Li Liu; Qi Bai; Chenzhang Ou; Ying Xiong; Yang Qu; Zewei Wang; Yu Xia; Jianming Guo; Jiejie Xu
Journal:  Oncoimmunology       Date:  2018-10-02       Impact factor: 8.110

Review 6.  Role of innate immunity in the development of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

7.  HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis.

Authors:  Celine Hernandez; Peter Huebener; Jean-Philippe Pradere; Daniel J Antoine; Richard A Friedman; Robert F Schwabe
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

8.  Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy.

Authors:  Christel Devaud; Jennifer A Westwood; Liza B John; Jacqueline K Flynn; Sophie Paquet-Fifield; Connie P M Duong; Carmen S M Yong; Hollie J Pegram; Steven A Stacker; Marc G Achen; Trina J Stewart; Linda A Snyder; Michele W L Teng; Mark J Smyth; Phillip K Darcy; Michael H Kershaw
Journal:  Mol Ther       Date:  2013-09-19       Impact factor: 11.454

Review 9.  Cancer-associated fibroblasts in hepatocellular carcinoma.

Authors:  Norio Kubo; Kenichiro Araki; Hiroyuki Kuwano; Ken Shirabe
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

10.  Tumor-infiltrating neutrophils predict poor outcome in adenocarcinoma of the esophagogastric junction.

Authors:  Pingping Hu; Zhaofei Pang; Hongchang Shen; Guanghui Wang; Haifeng Sun; Jiajun Du
Journal:  Tumour Biol       Date:  2014-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.